Principal Securities »

Cidara Therapeutics shares owned by Principal Securities

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Principal Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1k 12 95.75

More positions owned by Principal Securities

Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Principal Exchange Traded Focused Blue Chi (BCHP)
Principal Exchange Traded Prin U S Small (PSC)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Microsoft Corporation (MSFT)
Principal Exchange Traded Intl Equity Etf (PIEQ)
Ishares Tr Core S&p Us Vlu (IUSV)
Spdr Series Trust Portfolio S&p500 (SPLG)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Principal Exchange Traded Prnc Invt Grad (IG)
Ishares Tr Rus 1000 Etf (IWB)

View all positions for Principal Securities

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics